Latest Foundation Fighting Blindness Stories
Jan. 17 Event Will Honor Key Food Chief Executive; Special Guest Mrs. World Queens, NY (PRWEB) January 16, 2013 The Foundation Fighting Blindness, a national nonprofit that drives sight-saving research, will host its 2nd Annual ‘Una Visión Para El Futuro’ (A Vision for the Future) on Thursday, Jan. 17, at Terrace on the Park in Flushing Meadows Park. The event will honor the accomplishments and community involvement of Key Food Chief Executive Dean Janeway, as supermarket...
Biologists at Mainz University achieve repair and read-through of stop mutations responsible for the disease After years of basic research, scientists at Johannes Gutenberg University Mainz (JGU) are increasingly able to understand the mechanisms underlying the human Usher syndrome and are coming ever closer to finding a successful treatment approach. The scientists in the Usher research group of Professor Dr. Uwe Wolfrum are evaluating two different strategies. These involve either the...
VIENNA, Va., Sept. 19, 2012 /PRNewswire/ -- MyEyeDr. is pleased to announce it is a proud sponsor of the 2012 Montgomery County Vision Walk to benefit the Foundation Fighting Blindness, Inc., a non-profit organization with the mission to drive the research that will provide preventions, treatments, and cures for people affected by retinitis, pigmentosa (RP), macular degeneration, Usher syndrome and the entire spectrum of retinal degenerative diseases. (Logo:...
OXFORD, England, July 23, 2012 /PRNewswire/ -- -- Award of US$125,000 will support a second clinical site in Paris, France -- Oxford BioMedica plc ("Oxford BioMedica" or "the Company") (LSE: OXB), the leading gene-based biopharmaceutical company, today announces that the US non-profit organisation, the Foundation Fighting Blindness (FFB), has granted an award of US$125,000 to the Company via its translational research arm, the Foundation Fighting Blindness Clinical...
CLEVELAND, May 17, 2012 /PRNewswire/ -- On May 19th, thousands will join forces to raise awareness for those affected by retinal degenerative diseases. Money raised through VisionWalk supports the important research funded by the Foundation Fighting Blindness, a national 501(c)(3) organization. The walk is at Wade Oval, and thousands of family members of those affected by retinal degenerative diseases will show support. Registration is at 9a, and the Walk begins at 10a. One of...
A new gene therapy method developed by University of Florida researchers has the potential to treat a common form of blindness that strikes both youngsters and adults. The technique works by replacing a malfunctioning gene in the eye with a normal working copy that supplies a protein necessary for light-sensitive cells in the eye to function. The findings are published today (Monday, Jan. 23) in the Proceedings of the National Academy of Sciences online. Several complex and costly steps...
OXFORD, England, October 18, 2011 /PRNewswire/ -- -- Third ocular product partnered with Sanofi approved to enter clinical development -- Oxford BioMedica plc ("Oxford BioMedica" or "the Company") (LSE: OXB), the leading gene-based biopharmaceutical company, today announces that the US Food and Drug Administration (FDA) has approved its Investigational New Drug (IND) application for the Phase I/IIa clinical development of UshStat(R), a novel gene-based treatment for...
OXFORD, England, June 22, 2011 /PRNewswire/ -- - RetinoStat(R) Progress in Phase I Study in Wet Age-Related Macular Degeneration Oxford BioMedica plc ("Oxford BioMedica" or "the Company") (LSE: OXB), a leading gene therapy company, today announces that the first dose level of RetinoStat(R) is safe and well-tolerated at one month following treatment. RetinoStat(R) is a novel gene-based treatment for neovascular "wet" age-related macular degeneration (AMD), designed and...
The first two patients with common but incurable diseases of the eye that can lead to blindness have been enrolled early in a two phase groundbreaking clinical trial of therapy that researchers are hoping will heal the damage caused by the conditions. Advanced Cell Technology Inc. (ACT) announced Thursday the enrollment of the patients in the trials for Stargardt's Macular Dystrophy (SMD) and Dry Age-Related Macular Degeneration (Dry AMD). The patients were enrolled at the Jules Stein Eye...
The Foundation Fighting Blindness, a national nonprofit that drives eyesight-saving research, will honor Ophthalmologist and Virginia Eye Institute Founder Anthony D. Sakowski, Jr., M.D., F.A.C.S., at the Richmond Dining in the Dark event. The unique luncheon will take place at noon on June 16 at the Richmond Marriott. Richmond, VA (PRWEB) June 15, 2011 The Foundation Fighting Blindness, a national nonprofit that drives eyesight-saving research, will honor Ophthalmologist and Virginia...
